Method of treating a cancer by administering A 2′,5′-oligoadenylate analog
    91.
    发明授权
    Method of treating a cancer by administering A 2′,5′-oligoadenylate analog 失效
    通过施用A 2',5'-寡聚腺苷酸类似物治疗癌症的方法

    公开(公告)号:US07994152B2

    公开(公告)日:2011-08-09

    申请号:US12587608

    申请日:2009-10-09

    IPC分类号: A61K48/00 C07H21/02

    摘要: A method of treating a tumor or a viral disease by administering to a human the following 2′,5′-oligoadenylate analog: Wherein m is 0; n is 0 or 1; R1 is alkoxy substituted by hydroxyl, mercapto, alkylthio substituted by hydroxyl or X1—X2—X3—S—; R2, R3, R4, R5 and R6 are hydroxyl, mercapto, alkylthio substituted by hydroxyl or X1—X2—X3—S—; R7 is oxygen, sulfur, —NH—, or —O(CH2CH2O)q-, wherein q is 2 to 6, or oxyalkyleneoxy; R8 is hydrogen or a 5′-phosphorylated oligonucleotide which has one hydroxyl removed from the 5′-phosphoric acid; E1 is K2; E2 is K1; E3 is K2 or K3 and E4 is K1, K2 or K3; K1 is K2 is K3 is B is adeninyl; A is alkylene; D is alkyl or alkenyl; X1 is alkyl or phenyl; X2 is —C(═O)O—, —OC(═O)— or —C(═O)S—; and X3 is alkylene.

    摘要翻译: 一种通过向人施用以下2',5'-寡聚腺苷酸类似物来治疗肿瘤或病毒性疾病的方法:其中m为0; n为0或1; R1是被羟基取代的烷氧基,巯基,被羟基或X1-X2-X3-S-取代的烷硫基; R2,R3,R4,R5和R6是羟基,巯基,被羟基或X1-X2-X3-S-取代的烷硫基; R 7为氧,硫,-NH-或-O(CH 2 CH 2 O)q - ,其中q为2-6,或氧亚烷氧基; R8是从5'-磷酸除去一个羟基的氢或5'-磷酸化寡核苷酸; E1为K2; E2为K1; E3为K2或K3,E4为K1,K2或K3; K1是K2是K3是B是腺苷酸; A是亚烷基; D是烷基或烯基; X1是烷基或苯基; X2是-C(= O)O-,-OC(= O) - 或-C(= O)S-; X3是亚烷基。

    High Rebaudioside-A plant
    92.
    发明授权
    High Rebaudioside-A plant 有权
    高效甜菊苷 - 植物

    公开(公告)号:US07884265B2

    公开(公告)日:2011-02-08

    申请号:US11815400

    申请日:2006-03-02

    IPC分类号: A01H1/00 A23L1/236

    CPC分类号: A01H5/10 A01H5/12 A23L27/36

    摘要: A novel plant belonging to the Stevia Rebaudiana Bertoni variety which contains at least 4 parts by weight or more of Rebaudioside A with respect to one part by weight of Stevioside, and allows a sweetener of a good quality to be easily produced from said plant or dried leaves thereof.

    摘要翻译: 一种属于甜菊甜叶菊品种的新植物,相对于1重量份的甜菊苷,含有至少4重量份或更多的雷鲍迪甙A,并且允许从所述植物容易地产生高质量的甜味剂或干燥 叶子。

    NOVEL STEVIA VARIETY AND METHOD OF PRODUCING SWEETENER
    93.
    发明申请
    NOVEL STEVIA VARIETY AND METHOD OF PRODUCING SWEETENER 审中-公开
    新颖的史蒂维亚变种及其生产方法

    公开(公告)号:US20110023192A1

    公开(公告)日:2011-01-27

    申请号:US12863847

    申请日:2009-01-21

    摘要: High-purity stevioside sweeteners are being provided. Stevia Rebaudiana Bertoni varieties were identified using DNA analysis after cross and selective breeding were implemented. By crossing these varieties, a novel variety which enables continuous cultivation of the specific variety was developed (Deposition No. FERM BP-10870). Extracting the dried leaves of this variety assures consistent high-concentration of stevioside, which makes it possible to produce various favorable stevioside sweeteners.

    摘要翻译: 正在提供高纯度甜菊糖甜味剂。 使用DNA分析鉴定了经过交叉选育育种后的甜叶菊甜叶菊品种。 通过交叉这些品种,开发了能够连续培养特定品种的新品种(保藏号FERM BP-10870)。 提取这种品种的干燥叶子可确保一致的高浓度的甜菊苷,这使得可以生产各种有利的甜菊糖甜味剂。

    Photosetting type bio-based coating composition and its coated article
    94.
    发明申请
    Photosetting type bio-based coating composition and its coated article 审中-公开
    Photosetting型生物基涂料组合物及其涂层制品

    公开(公告)号:US20110009518A1

    公开(公告)日:2011-01-13

    申请号:US12787626

    申请日:2010-05-26

    IPC分类号: C08F2/46

    CPC分类号: C09D167/07 C08F2/48

    摘要: There are provided a photosetting type bio-based coating composition and its coated article, wherein the coating composition has a sufficient hydrolysis resistance and a sufficient crosslinking density so as to be excellent in such as long-term stability, and is inexpensive, and is applicable also to an aqueous solvent. The photosetting type bio-based coating composition according to the present invention is characterized by comprising: a bio-based photopolymerizable compound as a film-forming ingredient which compound has at least one lactic acid unit and at least one photopolymerizable group together in a molecule; and a photopolymerization initiator. The coated article according to the present invention is characterized by being obtained by being coated with the aforementioned coating composition.

    摘要翻译: 提供了一种光固化型生物基涂料组合物及其涂布制品,其中涂料组合物具有足够的耐水解性和足够的交联密度,从而具有优异的长期稳定性,并且价格便宜,适用 还涉及水性溶剂。 根据本发明的光固化型生物基涂料组合物的特征在于包括:化合物在分子中具有至少一个乳酸单元和至少一个光聚合基团的成膜成分的生物基光聚合化合物; 和光聚合引发剂。 根据本发明的涂布制品的特征在于通过涂覆上述涂料组合物获得。

    Oligonucleotide analogues and methods utilizing the same
    95.
    发明申请
    Oligonucleotide analogues and methods utilizing the same 有权
    寡核苷酸类似物和利用其的方法

    公开(公告)号:US20110009471A1

    公开(公告)日:2011-01-13

    申请号:US12804500

    申请日:2010-07-22

    摘要: A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.

    摘要翻译: 一种用于预防或治疗哺乳动物的疾病,其可通过所述哺乳动物体内的寡核苷酸类似物或其药理学上可接受的盐的药理学上有用的反义或反应活性可预防或治疗的疾病,所述方法包括向需要的所述哺乳动物施用 这样的预防或治疗药物有效量的包含两个或多个核苷单位的寡核苷酸类似物,其中所述核苷单元中的至少一个是式(2)的结构:其中A是亚甲基; 和B是未取代的嘌呤-9-基,未取代的2-氧代 - 嘧啶-1-基或取代的嘌呤-9-基; 或其药理学上可接受的盐。

    Oligonucleotide analogues and methods utilizing the same
    96.
    发明授权
    Oligonucleotide analogues and methods utilizing the same 有权
    寡核苷酸类似物和利用其的方法

    公开(公告)号:US07816333B2

    公开(公告)日:2010-10-19

    申请号:US11881775

    申请日:2007-07-27

    IPC分类号: A01N43/04 A61K31/70

    摘要: A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.

    摘要翻译: 一种用于预防或治疗哺乳动物的疾病,其可通过所述哺乳动物体内的寡核苷酸类似物或其药理学上可接受的盐的药理学上有用的反义或反应活性可预防或治疗的疾病,所述方法包括向需要的所述哺乳动物施用 这样的预防或治疗药物有效量的包含两个或多个核苷单位的寡核苷酸类似物,其中所述核苷单元中的至少一个是式(2)的结构:其中A是亚甲基; 和B是未取代的嘌呤-9-基,未取代的2-氧代 - 嘧啶-1-基或取代的嘌呤-9-基; 或其药理学上可接受的盐。

    2′, 5′-oligoadenylate analogs
    97.
    发明授权
    2′, 5′-oligoadenylate analogs 失效
    2',5'-寡腺苷酸类似物

    公开(公告)号:US07651999B2

    公开(公告)日:2010-01-26

    申请号:US11131412

    申请日:2005-05-16

    IPC分类号: A61K31/70 C07H21/02

    摘要: A 2-5A analog represented by the formula (1): wherein m is 0 or 1; n is 0 to 2; R1 represents an alkoxy group having from 1 to 6 carbon atoms which may be substituted, an unprotected mercapto group, a mercapto group protected by a nucleic acid synthesis protecting group, or an alkylthio group having from 1 to 4 carbon atoms which may be substituted; R2, R3, R4, R5 and R6 represent an unprotected hydroxyl group, a hydroxyl group protected by a nucleic acid synthesis protecting group, an alkoxy group having from 1 to 6 carbon atoms which may be substituted, an unprotected mercapto group, a mercapto group protected by a nucleic acid synthesis protecting group, or an alkylthio group having from 1 to 4 carbon atoms which may be substituted; R7 represents an oxygen atom, or a —O(CH2CH2O)q- group, wherein q is 2 to 6; R8 represents a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms which may be substituted, or a 5′-phosphorylated oligonucleotide analog which has one hydroxyl group removed from the 5′-phosphoric acid group; E1, E2, E3 and E4 represent a naturally occurring or modified nucleic acid unit, or a pharmacologically acceptable salt thereof.

    摘要翻译: 由式(1)表示的2-5A类似物:其中m为0或1; n为0〜2; R1表示可被取代的具有1至6个碳原子的烷氧基,未保护的巯基,被核酸合成保护基保护的巯基或可被取代的具有1至4个碳原子的烷硫基; R2,R3,R4,R5和R6表示未被保护的羟基,被核酸合成保护基保护的羟基,可被取代的具有1至6个碳原子的烷氧基,未保护的巯基,巯基 被核酸合成保护基保护,或可以被取代的具有1至4个碳原子的烷硫基; R 7表示氧原子,或-O(CH 2 CH 2 O)q-基,其中q为2-6。 R8表示氢原子,可以被取代的碳原子数为1〜6的烷基或从5'-磷酸基除去一个羟基的5'-磷酸化寡核苷酸类似物; E1,E2,E3和E4表示天然存在或修饰的核酸单元或其药理学上可接受的盐。

    FUEL INJECTION CONTROL APPARATUS AND FUEL INJECTION CONTROL METHOD FOR INTERNAL COMBUSTION ENGINE
    99.
    发明申请
    FUEL INJECTION CONTROL APPARATUS AND FUEL INJECTION CONTROL METHOD FOR INTERNAL COMBUSTION ENGINE 有权
    燃油喷射控制装置和燃油喷射控制方法内燃机

    公开(公告)号:US20090271091A1

    公开(公告)日:2009-10-29

    申请号:US12301625

    申请日:2007-07-23

    申请人: Koji Morita

    发明人: Koji Morita

    IPC分类号: F02D41/30 F02B17/00

    摘要: A fuel injection control apparatus for an internal combustion engine includes a fuel injection portion that performs each of first fuel injection for performing stratified-charge combustion, and second fuel injection for performing homogeneous-charge combustion; and an injection distribution ratio control portion that controls an injection distribution ratio. The injection distribution ratio control portion controls the injection distribution ratio to a target injection distribution ratio set based on a predetermined engine condition after start of the engine. An initial injection distribution ratio is set based on an engine condition at a time of start of the engine, and a change in the injection distribution ratio is controlled by referring to the engine condition after the start of the engine, when the injection distribution ratio is changed from the initial injection distribution ratio to the target injection distribution ratio.

    摘要翻译: 一种用于内燃机的燃料喷射控制装置,包括执行各自进行分层充气燃烧的第一燃料喷射的燃料喷射部和进行均匀充气燃烧的第二燃料喷射; 以及控制喷射分配比的喷射分配比控制部。 喷射分配比率控制部分将喷射分配比控制为基于发动机起动之后的预定发动机状态设定的目标喷射分配比。 基于发动机起动时的发动机状态来设定初始喷射分配比,并且通过参照发动机起动后的发动机状态来控制喷射分配比的变化,当喷射分配比为 从初始喷射分配比改变为目标喷射分配比。

    High Rebaudioside-A Plant
    100.
    发明申请
    High Rebaudioside-A Plant 有权
    高效甜菊苷A植物

    公开(公告)号:US20090214753A1

    公开(公告)日:2009-08-27

    申请号:US11815400

    申请日:2006-03-02

    IPC分类号: A23L1/28

    CPC分类号: A01H5/10 A01H5/12 A23L27/36

    摘要: A novel plant belonging to the Stevia Rebaudiana Bertoni variety which contains at least 4 parts by weight or more of Rebaudioside A with respect to one part by weight of Stevioside, and allows a sweetener of a good quality to be easily produced from said plant or dried leaves thereof.

    摘要翻译: 一种属于甜菊甜叶菊品种的新植物,相对于1重量份的甜菊苷,含有至少4重量份或更多的雷鲍迪甙A,并且允许从所述植物容易地产生高质量的甜味剂或干燥 叶子。